Results 151 to 160 of about 4,138 (179)

Overview of physics research on the TCV tokamak

Nuclear Fusion, 2009
The Tokamak à Configuration Variable (TCV) tokamak is equipped with high-power (4.5 MW), real-time-controllable EC systems and flexible shaping, and plays an important role in fusion research by broadening the parameter range of reactor relevant regimes, by investigating tokamak physics questions and by developing new control tools.
openaire   +1 more source

Upgrade of the neutral beam heating system on the TCV tokamak – second high energy neutral beam

Fusion Engineering and Design, 2023
Alexander N Karpushov, C Colandrea, Basil P Duval   +2 more
exaly  

Measurement of the magnetic field errors on TCV

Fusion Engineering and Design, 2010
J -M Moret
exaly  

TCV

2008
openaire   +1 more source

Quantitation of a new potent angiotensin II receptor antagonist, TCV-116, and its metabolites in human serum and urine

Biomedical Applications, 1996
Michio Motohashi, Takatsuka Yashiki
exaly  

TCV heating and divertor upgrades

Nuclear Fusion, 2019
A. Fasoli, H. Reimerdes, S. Alberti, M. Baquero-Ruiz, B.P. Duval, E. Havlikova, A. Karpushov, J.-M. Moret, M. Toussaint, H. Elaian, M. Silva, C. Theiler, D. Vaccaro   +12 more
openaire   +1 more source

Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats

European Journal of Pharmacology, 1998
Fumio Chatani
exaly  

Neutral beam heating on the TCV tokamak

Fusion Engineering and Design, 2017
Alexander N Karpushov, S Coda, Basil P Duval   +2 more
exaly  

Development of real-time plasma analysis and control algorithms for the TCV tokamak using Simulink

Fusion Engineering and Design, 2014
F Felici, B P Duval, S Coda
exaly  

Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive Rats

Clinical and Experimental Hypertension, 1997
Mami Ojima, Tsukasa Sanada, Yumiko Shibouta   +2 more
exaly